Literature DB >> 10846737

Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients.

D M Brown1, M A Jabra-Rizk, W A Falkler, A A Baqui, T F Meiller.   

Abstract

PURPOSE: The combination of an immature immune system and suppressed cellular immunity in children with HIV infections provides optimal conditions for rapid disease progression. As a result, pediatric AIDS has become a major epidemiological challenge. Oral fungal colonization remains one of the most common opportunistic infections observed in both adult and pediatric HIV infected patients. Although Candida albicans is the most frequently isolated opportunistic fungal species, a recently characterized Candida species, C. dubliniensis, has gained considerable attention due to its almost exclusive association with HIV-seropositive individuals. The purpose of this study was to prospectively screen for the presence of C. dubliniensis among pediatric HIV+ patients.
METHODS: Oral samples taken from twenty-seven children were cultured for the presence of yeast. All positive yeast isolates obtained were screened for the presence of C. dubliniensis by use of tests for germ tube and chlamydospore production, detection of inability to grow at 45 degrees C, by colony color on CHROMagar Candida medium, coaggregation with Fusobacterium nucleatum ATCC 49256 and by the results of sugar assimilation testing with the API 20C AUX yeast identification system.
RESULTS: Among the 27 patients tested, 3 patients were found to harbor C. dubliniensis, one of which also grew C. glabrata; 12 patients were colonized with C. albicans, while the remaining 12 patients were negative for yeast. Identification of the three C. dubliniensis isolates was genetically confirmed by electrophoretic karyotyping. All three C. dubliniensis isolates were found to be susceptible to fluconazole (MIC < or = 0.25 ug/ml).
CONCLUSIONS: These results confirm the presence of this novel species in a dental pediatric HIV seropositive population and support the need for further investigation into the prevalence and pathogenesis of C. dubliniensis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10846737

Source DB:  PubMed          Journal:  Pediatr Dent        ISSN: 0164-1263            Impact factor:   1.874


  5 in total

1.  Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis.

Authors:  K C Hazen; J G Wu; J Masuoka
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Rapid identification and differentiation of Candida albicans and Candida dubliniensis by capillary-based amplification and fluorescent probe hybridization.

Authors:  Rangaraj Selvarangan; Ajit P Limaye; Brad T Cookson
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.

Authors:  Sofia Perea; José L López-Ribot; Brian L Wickes; William R Kirkpatrick; Olga P Dib; Stefano P Bachmann; Suzanne M Keller; Marcos Martinez; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 4.  Candida dubliniensis: epidemiology and phenotypic methods for identification.

Authors:  Erico Silva Loreto; Liliane A Scheid; Cristina W Nogueira; Gilson Zeni; Janio M Santurio; Sydney H Alves
Journal:  Mycopathologia       Date:  2010-02-21       Impact factor: 2.574

5.  Candida dubliniensis infections in a pediatric population: retrospective identification from clinical laboratory isolates of Candida albicans.

Authors:  Jean O Kim; Lucille Garofalo; Deborah Blecker-Shelly; Karin L McGowan
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.